NCT02918617 - Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream | Biotech Hunter

Enrollment

203

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Dentin Sensitivity

Interventions

DRUG

Control toothpaste containing Novamin® technology

DRUG

Control toothpaste containing 1500 ppm fluoride as MFP

DRUG

Test toothpaste with nano-HAP (high concentration)

DRUG

Test toothpaste with nano-HAP (low concentration)

DRUG

Test toothpaste with nano-HAP and (Potassium Nitrate) KNO3

DRUG

Control toothpaste without nano-HAP

DRUG

Test toothpaste with nano-HAP (medium concentration)

DRUG

Test cream with nano-HAP (higher concentration)

DRUG

Control cream without nano-HAP

Trial Locations (1)

School of Dentistry, University of Texas Health Science Center, San Antonio

All Listed Sponsors

collaborator

Sangi Co., Ltd.

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER